# Decision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy

> **NCT06664541** · — · ENROLLING_BY_INVITATION · sponsor: **Georgetown University** · enrollment: 100 (estimated)

## Conditions studied

- Transfusion Dependent Beta Thalassemia
- Sickle Cell Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06664541
- **Lead sponsor:** Georgetown University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-10-01
- **Primary completion:** 2026-10-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06664541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06664541, "Decision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06664541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*